Retraction: Role of mesenchymal stem cells versus angiotensin converting enzyme inhibitor in kidney repair.

The retraction has been agreed due to duplications within Figure 2 and the inclusion of figure elements in Figure 1 and 2 that were previously published [1-4]. Thus, the conclusions of this article are considered invalid. The authors have been informed of the decision to retract but did not agree with it. References: 1. Hanaa H. Ahmeda, Wafaa Gh. Shoushab, El-Sayed M. El-Sayed Mahdyb, Laila A. Rashedc, Sara M. Abdob (2013), Influence of adipose tissue derived mesenchymal stem cells in combination with injectable bone substitute on osteoclastogenesis in osteoporotic rats. J Appl Pharm Sci, 3: 046-056. https://doi.org/10.7324/JAPS.2013.3809 2. Salem, A.M., Ahmed, H.H., Atta, H.M., Ghazy, M.A. and Aglan, H.A. (2014), RETRACTED: Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats. Cell Biol Int, 38: 1367-1383. https://doi.org/10.1002/cbin.10331 3. Ahmed H, Salem A, Atta H, Ghazy M, Aglan H. RETRACTED: Do adipose tissue-derived mesenchymal stem cells ameliorate Parkinson's disease in rat model? Human & Experimental Toxicology. 2014;33(12):1217-1231. doi: 10.1177/0960327114524238 4. Ahmed, H.H., Metwally, F.M., Khalil, W.K.B. et al. Bone marrow derived mesenchymal stem cells: A unique cytotherapy for rescuing degenerated dopaminergic neurons. Neurochem. J. 9, 284-294 (2015). https://doi.org/10.1134/S1819712415040029.